|
|
|
| 2008 |
Human Proteome Organization Initiatives
Meeting "Proteomic Mapping of Endothelial Cell Surface and its Caveolae"
(Bridgetown, Barbados) |
| 2008 |
NIH Mitochondria Minisymposium "Proteomic
Approaches to Organelles in the CV System" (Washington, DC) |
2007
|
International Society for
Cell and Gene Therapy for Cancer Cell and Gene Therapy Conference “Targeting
the Caveolae Proteome to Overcome Endothelial Cell Barriers to Vector
Delivery in Vivo” (Mumbai, India)
|
| 2007 |
Human Proteome Organization 6th Annual
World Congress, Nano Imaging Technology for Biomarker Discovery “Discovery
and Validation of Accessible Cancer Targets through Organellar Proteomic
Imaging In Vivo” (Seoul, Korea) |
| 2007 |
National Cancer Institute Nanotechnology
Alliance Investigators Meeting, Nanotechnology Platform for Targeting
Solid Tumors” (Chapel Hill, NC) |
| 2007 |
Medical University of South Carolina, Hollings
Cancer Center Seminar Series “Proteomic Imaging of Endothelium
and its Caveolae In Vivo: Enhanced Tumor Penetration and Radioimmunotherapy” (Charleston,
SC) |
| 2007 |
|
8th World Congress for Microcirculation, Plenary
Lecture: “Proteomic Mapping of the Endothelium” (Milwaukee,
WI) |
| 2007 |
|
FASEB Summer Research Conference, Lipid Signaling
Pathways in Cancer, “Proteomic Mapping of Caveolae Signaling
in Vascular Endothelium for Targeted Therapy” (Indian Wells,
CA) |
| 2007 |
|
XXIst Congress of the International Society on
Thrombosis and Haemostasis, “Vascular Proteomics” (Geneva,
Switzerland) |
| 2007 |
|
Vanderbilt Univ, Frontiers in Biomedical Imaging
Science, “Discovery and Classes of Targets for Imaging” (Nashville,TN) |
| 2007 |
|
University of Connecticut Health Center, Vascular
Biology Seminar Series, “Coupling Systems Biology with
in Vivo Proteomic Imaging of Endothelial Caveolae to Discover Targets
for Cancer and Other Diseases” (Farmington, CT) |
| 2007 |
|
UCSD Nano Tumor Center/Moores Cancer Center, Fighting
Cancer with Nanotechnology, “Using Nanotechnology to
Enable In Vivo Proteomic Imaging of Endothelium and its Caveolae
for Targeted Penetration into Organs and Solid Tumors” (San
Diego, CA) |
| 2007 |
|
Nobel Symposium, Watching Life Through Molecular
Imaging, “Integrating Proteomic Mapping and Molecular
Imaging of Endothelium to Target Specific Organs and Solid Tumors” (Stockholm,
Sweden) |
| 2007 |
|
North American Vascular Biology Organization Vascular
Biology 2007, Proteogenomic Mapping of Vascular Phenotypes in Health
and Disease “Proteomic Imaging of Endothelial Cell Surfaces
and Caveolae In Organs and Solid Tumors” (Washington, DC) |
| 2007 |
|
University of California, Los Angeles, Pharmacology
Seminar Series, “Proteomic Imaging of Endotheliujm & Its
Caveolae In Vivo For Enhanced Antibody Penetration into Organs & Tumors” (Los
Angeles, CA) |
| 2007 |
|
University of California, San Diego, Moores Cancer
Center, Translational Research Evening with the Sidney Kimmel
Cancer Center, “In Vivo Proteomic Imaging and Immunotargeting
of Endothelial Caveolae to Penetrate into Lung and Solid Tumors” (San
Diego, CA) |
| 2007 |
|
AACR 2007 Annual Meeting, A Century of Leadership
in Science—A Future of Cancer Prevention and Cures: Advances
in Nanotechnology Applications of Cancer Research “Using
Nanotechnology to Map and Target Endothelium and its Caveolae In
Vivo for Solid Tumor Penetration and Destruction” (Los Angeles,
CA) |
| 2007 |
|
Emory-Georgia Tech CCNE/BRP Cancer Nanotechnology
Symposium, “Using Nanotechnology for Vascular Proteomic
Mapping and Targeted Penetration into Specific Organs and Solid
Tumors In-Vivo” (Atlanta, GA) |
| 2007 |
|
2nd Annual Nanotechnology and the Life Sciences
Symposium, “Proteomic Profiling of Endothelium and its
Caveolae to Target Organs and Solid Tumors: Overcoming In Vivo
Barriers to Nanoparticle Delivery” (St. Louis, Mo) |
| 2007 |
|
Boston University School of Medicine, Whitaker Cardiovascular
Institute Seminar, “Proteomic Imaging of Luminal Endothelial
Surfaces and Caveolae In Vivo: Delivery Pathway into Specific Organs
and Solid Tumors” (Boston, MA) |
| 2007 |
|
University of Nebraska Medical Center, Center
for Drug Delivery and Nanomedicine Seminar Program, “Overcoming
Barriers to Nanoparticles In Vivo by Targeting Caveolae in Endothelium:
Towards Rapid Penetration of Solid Tumors and Organs” (Omaha,
NB) |
| 2007 |
|
4th International Sidney Kimmel Cancer Center Annual
Meeting, New Targets and Delivery Systems in Cancer Diagnosis
and Treatment, “Proteomic Mapping and Imaging of Endothelium
for Penetration into Solid Tumors” (San Diego, CA) |
| 2007 |
|
AACR Advances in Proteomics in Cancer Research “Proteomic
Imaging of Rodent and Human Tumor Endothelium In Vivo: Applying Systems
Biology to Find Targets for Penetrating Solid Tumors” (Amelia
Island, FL) |
| 2007 |
|
Keystone Symposia, Antibodies as Drugs “Organ
and Tumor-Specific Transcytotic Antibody Delivery via Targeting of
Endothelial Caveolae” (Alberta, Canada) |
| 2007 |
|
Keystone Symposia, Integrative Basis of Cardovascular
Disease, “Proteomic Mapping and Imaging of Vascular Endothelium
and its Caveolae for Tissue Targeting and Penetration” (Breckenridge,
CO) |
| 2007 |
|
The Wistar Institute, Cancer Seminar Series “Proteomic
Mapping of Endothelium and its Caveolae for Antibody Penetration
into Solid Tumors” (Philadelphia, PA) |
| 2007 |
|
Case Western University Seminar, The Jerome I.
Kleinerman Lectureship “Proteomic Mapping and Immunotargeting
of Endothelial Caveolae for Solid Tumor Penetration and Radio-Destruction
(Cleveland, Ohio) |
| 2006 |
|
ASCB Annual Meeting, Transport via Caveolae “Proteomic
Imaging of Endothelial Caveolae: Rapid Active Transcytotic Pumping
of Targeting Antibodies In Vivo” (San Diego, CA) |
| 2006 |
|
HUPO 5th World Congress, Translating Proteomics
from Bench to Bedside “Moving Towards Rapid Target Discovery
and Validation” (Long Beach, CA) |
| 2006 |
|
HUPO Educational Forum at 5th World Congress “Target
Discovery & Validation in Clinical Proteomics” (Long Beach,
CA) |
| 2006 |
|
Case Western University Seminar, “Proteomic
Mapping and Immunotargeting of Endothelium and its Caveolae for Improved
Tumor Penetration, Imaging and Therapy” (Cleveland, Ohio) |
| 2006 |
|
International Society for Biological Therapy of
Cancer, 21st Annual Meeting, Plenary Lecture: “In Vivo
Proteomic Mapping of Intravenously Accessible Targets of Vascular
Endothelium and Its Caveolae in Organs and Solid Tumors for Tissue-Specific
Imaging and Immunotherapy” (Los Angeles, CA) |
| 2006 |
|
National Cancer Institute, NCI Alliance for Nanotechnology
in Cancer Investigators Meeting, Plenary Presentation: “Clinical
Promise of Nanomedicine: Delivery and Penetration of Pathways Into
Solid Tumors” (San Diego, CA) |
| 2006 |
|
Yonsei University Seminar, “Subtractive Proteomic
Mapping of Vascular Endothelia In Vivo for Immunotargeted Penetration
Into Organs & Solid Tumors” (Seoul, Korea) |
| 2006 |
|
Samsung Medical Center, 12th Samsung International
Symposium: Nanomedicine in Cancer, “Proteomic Mapping
of Endothelium and Its Caveolae for Improved Tumor Penetration,
Imaging and Therapy with Nanoparticles” (Seoul, Korea) |
| 2006 |
|
4th International Kloster Seeon Meeting on Angiogenesis: Molecular
Mechanisms and Functional Interactions, “Proteomic Imaging
of Microenvironment-Dependent Expression in Endothelium and its
Caveolae for Organ- and Tumor-Specific Delivery In Vivo” (Seeon,
Germany) |
| 2006 |
|
National Cancer Institute, Seventh Principal Investigators
Meeting for the Innovative Molecular Analysis Technologies (IMAT)
Program, “Mapping Endothelium and Its Caveolae In Vivo
to Improve Antibody Penetration, Imaging and Therapy of Solid Tumors” (Bethesda,
MD) |
| 2006 |
|
National Cancer Advisory Board Meeting, Progress
Report: NCI Innovative Molecular Analysis Technology (IMAT) Program, “Proteomic
Mapping of Blood Vessel Surfaces and Caveolae In Vivo to Improve
Antibody Penetration, Imaging and Therapy of Solid Tumors” (Bethesda,
MD) |
| 2006 |
|
Gordon Conference, Drug Carriers in Medicine & Biology, “Proteomic
Mapping of Endothelial Caveolae In Vivo to Improve Antibody Penetration,
Imaging and Therapy of Solid Tumors” (Big Sky, Montana) |
| 2006 |
|
Max Planck Institute, Seminar: “Proteomic Mapping
and Imaging of Endothelial Caveolae in Vivo: Targeting Transcytosis
for Pharmacodelivery” (Dresden, Germany) |
| 2006 |
|
International Symposium on Cardiovascular Biology, “Unraveling
New Vasoactive Mechanisms Integrating Endothelial Caveolae Signaling
and Trafficking Through Large-Scale Proteomic Mapping and Molecular
Imaging In Vivo” (Prague, Czech Republic) |
| 2006 |
|
5th International Congress on Recombinant Antibodies, “Proteomic
Mapping and Immunotargeting of Endothelium and its Caveolae for Improved
Tumor Penetration, Imaging and Therapy” (Zurich, Switzerland |
| 2006 |
|
National Cancer Institute, “Imaging Tumors and
Their Microenvironments Workshop” (Alexandria VA) |
| 2006 |
|
Southern Swedish Oncology Society, Lund University
Hospital, Targeted Therapy in Cancer “Vascular Targeting
in the Treatment of Cancer” (Lund, Sweden) |
| 2006 |
|
Novo Nordisk Foundation Consortium Workshop on Vascular
Biology in Diabetes Complications “Proteomic Mapping
and Screening Phage Display Libraries for Organ-Specific Vascular
Immunotargeting In Vivo” (Stockholm, Sweden) |
| 2006 |
|
International Journal Human Antibodies and the Rajko
Medenica Research Foundation / Shantha West, Inc., Human Antibodies & Hybridomas
Conference, “Proteomic Mapping & Immunotargeting of
Endothelial Caveolae for Transcytosis and Penetration Into Solid
Tumors and Lungs” (Montego Bay, Jamaica) |
| 2006 |
|
University of West Virginia School of Medicine, Cell
and Molecular Biology Seminar Series, “Proteomic Mapping
and Imaging of Vascular Endothelium and its Caveolae in Organs
and Solid Tumors for Novel Targeted Therapies” (Morgantown,
WV) |
| 2006 |
|
Massachusetts General Hospital / Harvard Cutaneous
Biology Research Center Seminar “Proteomic Mapping of Endothelium
and its Caveolae In Vivo for Targeted Penetration into Single Organs
and Solid Tumors” (Boston, MA) |
| 2006 |
|
Korean National Cancer Center “Proteomic Mapping & Immunotargeting
of Endothelium and Its Caveolae for Improved Tumor Penetration, Imaging
and Therapy” (Seoul, Korea) |
| 2006 |
|
Yonsei University Medical Center Seminar “Proteomic
Mapping & Immunotargeting of Endothelium and Its Caveolae for
Improved Tumor Penetration, Imaging and Therapy” (Seoul, Korea) |
| 2006 |
|
Samsung Medical Center Seminar “Immunotargeting
to Penetrate Single Organs and Solid Tumors In Vivo Via the Distinct
Proteomic Signatures of Endothelium and its Caveolae” (Seoul,
Korea) |
| 2006 |
|
KHUPO 6th Annual International Proteomics Conference From
Bench to Clinical Application “Proteomic Mapping & Immunotargeting
of Endothelium and Its Caveolae for Improved Tumor Penetration,
Imaging and Therapy” (Seoul, Korea) |
| 2006 |
|
2nd Annual USHUPO Proteomics Conference “Mapping
Plasma Membranes, Caveolae & Lipid Rafts of Endothelium: Distince
Molecular Architecture and Signaling and Trafficking Pathways In
Vivo” (Boston, MA) |
| 2006 |
|
3rd International SKCC Conference Proteogenomics
For Diagnosis, Imaging And Therapy Of Cancer, “Proteomic
Mapping & Targeting of Endothelium and Its Caveolae for Improved
Tumor Penetration, Imaging and Therapy” (San Diego, CA) |
| 2006 |
|
Nature Publishing International Winter Science Conference Angiogenesis
in Cancer and Vascular Disease, “Proteomic Mapping and
Imaging of Endothelium and its Caveolae to Identify Accessible
Immunotargets for Specific Penetration into Solid Tumors and Major
Organs” (Miami, FL) |
| 2006 |
|
NAVBO Developmental Vascular Biology Workshop
II, “Proteomic Mapping and Imaging of Vascular Endothelium
In Vivo Reveals Distinct Molecular Signatures in Major Organs and
Solid Tumors” (Pacific Grove, CA) |
| 2006 |
|
Cambridge Healthtech Institute’s 6th Annual The
Plasma Proteome: High Abundance vs Low Abundance. Discovering Biological
Markers for Diagnostics and Drug Discovery, “Towards
Comprehensive Proteomic Mapping of Blood Vessels through Prefractionation
and Multi-modal MS Analysis” (San Diego) |
| 2005 |
|
NCI Proteomic Technologies Reagents Resource Workshop (Chicago,
IL) |
| 2005 |
|
IBC International Conference on Clinical Biomarkers, “Unmasking
Vascular and Caveolar Biomarkers of Solid Tumors for Targeted Imaging
and Therapy” (Boston, MA) |
| 2005 |
|
AACR/NCI/EORTC-sponsored International Oncology Meeting
on Molecular Targets and Cancer Therapy, “Attacking
Accessible Tumor Targets via Proteomic Mapping and Imaging of Vascular
Endothelium and Its Caveolae In Vivo” (Philadelphia, PA) |
| 2005 |
|
Cold Spring Harbor Laboratory Meeting on Target
Definition &Vector Design for Molecular Medicine, “Proteomic
Mapping of Endothelial Cell Surfaces and Caveolae for Immunotargets
Accessible in Organs and Solid Tumors” (Cold Spring Harbor,
NY) |
| 2005 |
|
University of Missouri, Columbia Physiology Department
Seminar: “Proteomic Mapping and Functional Imaging of Endothelium
and its Caveolae in Vivo: Rapid Antibody Penetration into Solid Tumors” (Columbia,
MO) |
| 2005 |
|
TRDRP Conference 2005: 15 Years of Progress in
the Fight Against Tobacco, “Proteomic Mapping of Endothelium
and its Caveolae to Attack, Penetrate and Destroy Lung Tumors” (Los
Angeles, CA) |
| 2005 |
|
University of California, San Diego Medical Center,
Moores Cancer Center, Oncology Symposium on Targeted Therapies
in Oncology “Identification of Novel Targets in the Vascular
Compartment of Tumors” (San Diego, CA) |
| 2005 |
|
Imaging in 2020: Insights Through Imaging, "Targeting
the Endothelial Cell Surface for Imaging and Therapy” (Jackson
Hole, WY). |
| 2005 |
|
University of California, San Diego Medical Center,
Moores Cancer Center, seminar “Proteomic Mapping of Tumor Endothelium
and its Caveolae for Specific Imaging and Therapy” (San Diego,
CA) |
| 2005 |
|
4th Annual Meeting of the Society for Molecular Imaging, “Dynamic
Live Imaging of Antibody Targeting Endothelium and Its Caveolae in
Lung and Solid Tumors” (Cologne, Germany) |
| 2005 |
|
Human Proteome Organization 4th Annual World Congress, “Proteomic
Mapping of Distinct Molecular Signatures at Luminal Endothelial Cell
Surfaces in Organs and Solid Tumors for Imaging and Therapy” (Munich,
Germany) |
| 2005 |
|
1st International Conference, Exploring the Future
of Local Vascular and Inflammatory Mediators, “Proteomic
Mapping of Endothelial Cell Surfaces & Caveolae In Vivo: Defining
Molecular Architecture and Function to Targeting Specific Organs
and Solid Tumors” (Lund, Sweden) |
| 2005 |
|
Biomarker World Congress, Biomarkers in Clinical
Development, “Identifying Accessible Endothelial Biomarkers
in SolidTumors Via Subtractive Proteomics and Molecular Imaging” (Philadelphia,
PA) |
| 2005 |
|
Cleveland Clinic Taussig Cancer Center Seminar, “Caveolae
Trafficking and Signalling in Endothelium for Targeted Drug and Gene
Therapy” (Cleveland, OH) |
| 2005 |
|
Massachusetts General Hospital, Seminar “Proteomic
Mapping and Imaging of Luminal Endothelial Surfaces and Caveolae
for Targeting Specific Organs and Solid Tumors in Vivo” (Boston,
MA) |
| 2005 |
|
96th Annual International AACR Conference, Bio-sensors
and the Signatures of Angiogenic Tumor Vasculature: Tools for Early
Detection and Monitoring Therapeutic Responses, “Targeting
Endothelial Caveolae for Tumor-Specific Delivery in Vivo” and “Proteomic
Mapping Luminal Surfaces of the Tumor Vasculature” (Anaheim,
CA) |
| 2005 |
|
Seattle Genetics, Seminar “Proteomic Mapping
and Immunotargeting of Vascular Endothelium and its Caveolae in Single
Organs and Solid Tumors in Vivo” (Seattle, Washington) |
| 2005 |
|
United States Human Proteome Organization 1st Annual
International Conference; Mapping the Human Proteome: From Tools
to Functionality “Proteomic Mapping and Molecular Imaging
of Distinct Molecular Signatures at Luminal Endothelial Cell Surfaces
and Caveolae in Organs and Solid Tumors” (Washington, DC) |
| 2005 |
|
2nd International SKCC Conference Immune, Vascular
and Gene Targeting for Cancer Imaging Therapy, “Immunotargeting
and Imaging Solid Tumors via Subtractive Proteomic Mapping of Vascular
Endothelium and its Caveolae” (San Diego, CA) |
| 2005 |
|
Keystone Symposia Antibody-Based Therapeutics for
Cancer, “Immunotargeting Endothelial Caveolae to Improve
Penetration, Imaging and Therapy of Solid Tumors” (Santa
Fe, NM) |
| 2005 |
|
7th International Symposium on Anti-Angiogenic Agents “Proteomic
Mapping of Neovascular Endothelium and its Caveolae for Immunotargeting
Solid Tumors In Vivo” (La Jolla, CA) |
| 2005 |
|
McGill University, Seminar, “Proteomic Mapping
of Luminal Endothelial Cell Surfaces and Caveolae In Vivo for Targeted
Imaging and Therapy to Single Organs and Solid Tumors” (Montreal,
Canada) |
| 2005 |
|
NCI Strategies to Integrate Biomarkers Conference, “Proteomic
Mapping and Imaging of the Endothelium and its Caveolae In Vivo for
Targeting Therapy to Solid Tumors” (Houston, TX) |
| 2005 |
|
MD Anderson Grand Rounds, “Proteomic Mapping
and Imaging of the Endothelium and its Caveolae In Vivo for Targeting
Therapy to Solid Tumors” (Houston, TX) |
| 2005 |
|
Genentech, Seminar, “Proteomic Mapping and Imaging
of the Endothelium and its Caveolae In Vivo for Targeting Solid Tumors
and Single Organs” (So. San Francisco, CA) |
| 2005 |
|
Bracco Radiology Research, Seminar, “Proteomic
Mapping of the Endothelium for Tissue-Specific Imaging” (Princeton,
NJ) |
| 2004 |
|
15th International Antibody Engineering Conference “Integrative
Proteomic Mapping and Molecular Imaging of Endothelial Caveolae Identifies
Accessible Immunotargets for Solid Tumor Penetration and Radioimmunotherapy” (San
Diego, CA) |
| 2004 |
|
Cambridge Health Institute In Vivo Molecular Imaging
Meeting, “Tumor Target Discovery and Validation through Integration
of Subtractive Proteomics and Molecular Imaging In Vivo” (La
Jolla, CA) |
| 2004 |
|
Cambridge Health Institute Eighth Annual Functional
Genomics Meeting, “Rapid Discovery and Validation of Accessible
Tissue-Specific Targets” (Boston, MA) |
| 2004 |
|
Vascular Targeting Agents Therapeutic and Diagnostic
Development Conference, (Keynote Speaker) “Proteomic Mapping
and Immunotargeting of Endothelium and its Caveolae for Organ- and
Tumor-Specific Imaging and Therapy Tissue ” (Cambridge, MA) |
| 2004 |
|
American Heart Association Annual Meeting 2004, “Differential
Proteome, Signal Regulation and Trafficking in Caveolae vs. Lipid
Rafts” (New Orleans, LA) |
| 2004 |
|
M.D. Anderson, Research Imaging Seminar, “Rapid
Discovery and Validation of Accessible Tumor Vascular Targets via
Subtractive Proteomics and Molecular Imaging (Houston, TX) |
| 2004 |
|
AACR Advances in Proteomics in Cancer Research, “Unmasking
Specific IV-accessible Targets in Endothelial Caveolae of Solid Tumors
via Prefractionated Subtractive Proteomics and Molecular Imaging” (Key
Biscayne, FL) |
| 2004 |
|
16th EORTC – NCI – AACR Symposium on Molecular
Targets and Cancer Therapeutics, “Subtractive Proteomic
Mapping of the Endothelial Surface” (Geneva Switzerland) |
| 2004 |
|
Third Annual Meeting of the Society for Molecular
Imaging, Enhancing Delivery and Traversing Barriers (co-chair), “Mapping
and Targeting Caveolae to Overcome Endothelial Cell Barriers for
Tissue- and Tumor-Specific Delivery in Vivo” (St. Louis, MO) |
| 2004 |
|
Gordon Research Conference, Endothelial Cell Phonotypes
in Health and Disease, “Direct Proteomic Mapping and
Functional Imaging of the Endothelial Cell Surface and its Caveolae
in Vivo” (Andover, NH) |
| 2004 |
|
Third Annual Congress on the Future of Breast Cancer, “Caveolae:
Mining Little Caves for New Cancer Treatment” (Southampton,
Bermuda) |
| 2004 |
|
Second International Conference on Vascular Targeting, “Unmasking
Accessible Targets on Endothelial Cell Surface and its Caveolae for
Radioimmunotherapy and Imaging of Solid Tumors” (Miami, FL) |
| 2004 |
|
Mayo Clinic, Seminar, “Proteomic Mapping of
Endothelium and its Caveolae for Rapid Organ- and Tumor-specific
Imaging, Transcytosis, and Therapy in Vivo” (Rochester, MN) |
| 2004 |
|
Keystone Symposia, G-Protein-Coupled Receptors:
Evolving Concepts and Drug Discovery, “Differential Integration
of Signaling and Trafficking in Caveolae and Lipid Rafts by G Proteins
and CPCRs” (Taos, New Mexico) |
| 2004 |
|
International Conference on Genomics, Signaling
and Tumor Targeting, “Unmasking specific IV-accessible
immunotargets in lung and solid tumors via prefractionated subtractive
proteomics and molecular imaging in vivo.” (San Diego, CA) |
| 2004 |
|
American Association of Cancer Research Advances
in Cancer Research, “Unmasking IV-Accessible Tumor Vascular
Targets by Tissue Subfractionation, Subtractive Proteomics and
Molecular Imaging” (Waikoloa, Hawaii) |
| 2003 |
|
American Society of Cell Biology, 43rd Annual Meeting, “Distinct
Mechanisms of Endocytosis for Antibodies Targeting Mature Caveolae
vs. Sequestering GPI-AP in Lipid Rafts to Form New Caveolae” (San
Francisco, CA) |
| 2003 |
|
Immunogen Corporation Lecture, “Unmasking Endothelial
Cell Surface Proteins for Targeting Solid Tumors in Vivo” (Boston,
MA) |
| 2003 |
|
12th International Conference on Gene Therapy of
Cancer, “Mapping Accessible Tumor Vascular Targets through
Subtractive Proteomics and Molecular Imaging in Vivo” (San
Diego, CA) |
| 2003 |
|
Molecular Imaging Program at Stanford (MIPS) Seminar
Series, “Unmasking IV-Accessible Vascular Targets Specific
to Solid Tumors and Single Organs by Tissue Subfractionation, Subtractive
Proteomics, and Molecular Imaging” (Stanford, CA) |
| 2003 |
|
Northwestern University Division of Nephrology/Hypertension, “Function
of Caveolae in Vascular Endothelium: Proteomic Mapping and Imaging
for Tissue Specific Delivery” (Chicago, IL) |
| 2003 |
|
University of Illinois at Chicago, Department of Pharmacology,
College of Medicine, “Molecular Architecture and Function of
Caveolae in Endothelium” (Chicago, IL) |
| 2003 |
|
California Breast Cancer Research Program 2003 Symposium, From
Research to Action: A Decade of Progress in San Diego, “Targeting
Breast Cancer Blood Vessels” (San Diego, CA) |
| 2003 |
|
American Heart Association, 57th Annual Fall Conference
and Scientific Sessions of the Council for High Blood Pressure
Research in association with the Council on Kidney in Cardiovascular
Disease, Special Keynote Lecture, “Caveolae Integrate
Signaling and Trafficking as Sensore of Hemodynamic Flow and Vasoactivators” (Washington,
DC) |
| 2003 |
|
Second Annual Meeting of The Society for Molecular
Imaging. “The Vascular Proteome: Tissue-specific Imaging of
the Vasculature from the Whole Body to Electron Microscopy” (San
Francisco, CA) |
| 2003 |
|
National Heart, Lung and Blood Institute’s Symposium, From
Genome to Disease: A Symposium of High Throughput Biology, Microarray
Technology, “The vascular proteome: Mapping endothelium
and its caveolae for tissue-specific pharmacodelivery and imaging
in vivo” (Bethesda, MD) |
| 2003 |
|
National Cancer Institute, The Fourth Principal Investigator’s
(PI) Meeting of the Innovative Molecular Analysis Technologies (IMAT)
Program, Exploring Human Cancer: “Vascular Proteomics:
Mapping targets on endothelia and caveolae in vivo for organ- and
tumor-directed delivery and transcytosis” (San Diego, CA) |
| 2003 |
|
American Thoracic Society International Conference, Rafts
and Caveolae: Lipid Microdomains and Cell Signaling in the Lung: “Insights
From the Proteome of Caveolae: From Basic Mechanosignaling and
Trafficking to Clinical Targets for Lung-Specific Pharmacodelivery” (Seattle,
WA) |
| 2003 |
|
Stanford University, Division of Pulmonary Medicine: “Caveolae
Trafficking and Vascular Proteomic Mapping for Organ- and Tumor-Specific
Targeting in Vivo” (Stanford, CA) |
| 2003 |
|
National Cancer Institute Seminar, “Proteomic
Mapping of Endothelium and Its Caveolae for Targeting Single Organs
and Solid Tumors In Vivo” (Bethesda, MD) |
| 2003 |
|
Human Genome 2003 International Conference , “Cancer
angiomics: Mapping accessible vascular targets for molecular imaging
and therapy” (Cancun, Mexico) |
| 2003 |
|
American Physiological Society, Experimental Biology
2003, Translating the Genome, Caveolar Domains in Cell Signaling; “Lipid
Rafts and Caveolae” (San Diego, California) |
| 2003 |
|
University of Miami, Department of Cell Biology and
Anatomy: “Endothelium and its caveolae: From trafficking mechanisms
to proteomic mapping for tumor targeting in vivo” (Miami, Florida) |
| 2003 |
|
San Diego State University, Department of Biology: “Mechanotransduction
at the endothelial cell surface in caveolae: The roles of sphingomyelinase
and ceramide.” (San Diego, California) |
| 2003 |
|
Xenogen Corporation Lecture: “Vascular Proteomics
and Targeting for Imaging Single Organs and Solid Tumors” (Alameda,
California) |
| 2003 |
|
Cold Springs Harbor Laboratory International Gene
Therapy Conference, Vector Targeting Strategies for Gene Therapy; “Mapping
targets on endothelia and caveolae in vivo for organ- and tumor-directed
delivery and transcytosis” (Cold Spring Harbor, New York) |
| 2003 |
|
2nd International Workshop on New Therapeutic
Targets in Vascular Biology; “Vascular Proteomics” (Geneva,
Switzerland) |
| 2003 |
|
University of Michigan Grand Rounds Seminar: “Proteomic
Mapping of Endothelium for Organ- and Tumor-Specific Delivery and
Imaging in Vivo” (Ann Arbor, MI) |
| 2003 |
|
University of Alabama Birmingham School of Medicine: “Vascular
endothelium and its caveolae: From mechanisms of mechanosignaling
and trafficking to proteomic mapping for tumor targeting and imaging
in vivo” (Birmingham, AL) |
| 2002 |
|
American Society of Cell Biology, The endocytosis
and trafficking of caveolae/raft domains; “Differential
signal regulation of trafficking in caveolae and lipid rafts.” (San
Fransisco, CA) |
| 2002 |
|
Tobacco Related Disease Research AIM 2002 Conference, Vascular
Targeting of Lung Tumors (San Jose, CA) |
| 2002 |
|
Emory University School of Medicine: “Vascular
endothelium and its caveolae: from mechanisms of mechanosignaling
and trafficking to proteomic mapping for tumor targeting and imaging
in vivo” (Atlanta, GA) |
| 2002 |
|
Dartmouth-Hitchcock Medical Center, Norris Cotton
Cancer Center: “Vascular endothelium and its caveolae: From
signal regulation of trafficking to proteomic mapping for tumor targeting
and imaging in vivo” (Lebanon, NH) |
| 2002 |
|
American Heart Association Annual Meeting; Symposium
on: Caveolae and caveolin in cardiovascular biology; “Differential
trafficking and signaling in caveolae and lipid rafts, (Chicago,
IL) |
| 2002 |
|
Schering Lecture; “Vascular proteome and targeting
of specific organs and solid tumors in vivo”, (Berlin, Germany) |
| 2002 |
|
International Conference on Translational Cancer
Research and Therapy, “Accessible Functional Proteomics: Mapping
the Molecular Heterogeneity of Endothelia and Caveolae for Transcytosis & Tissue-Targeted
Therapy in Vivo”, (Tianjin, China) |
| 2002 |
|
National Cancer Institute Drug Discovery & Therapeutics
Seminar Series, “Accessible functional proteomics: Mapping
caveolae & endothelial cell surface proteins for organ- and tumor-specific
targeting in vivo.” (Frederick, MD) |
| 2002 |
|
Annual Meeting of the Society of Molecular Imaging, “Angiomics:
Identifying & targeting accessible tissue-specific proteins on
endothelium in vivo” (Boston, MA) |
| 2002 |
|
First International Conference on Vascular Targeting, “The
Proteome of Endothelium and its Caveolae: Organ – and Tumor – Specific
Targeting and Transcytosis in vivo” (Cambridge, MA) |
| 2002 |
|
National Institutes of Health/National Cancer Institute
Workshop on Caveolae/rafts and Cancer, “Caveolae: Basic
trafficking mechanisms to targeted tumor delivery in vivo” [Co-organizer & Co-chair]
(Washington, D.C.) |
| 2002 |
|
Harvard Medical School, Children's Hospital, “Tumor
Angiomics & Endothelial cell caveolae function & targeting” (Boston,
MA) |
| 2002 |
|
Department of Energy Workshop on Imaging Gene
Expression In Vivo, Keynote Address, “Angiomics and membrane
trafficking into the cell: Identifying accessible tissue-specific
targets on endothelium in vivo” (Boston, MA) |
| 2001 |
|
EURESCO Conference: Microdomains, Lipid Rafts and
Caveolae, “Cell Surface Signaling and Trafficking by
Caveolae and Lipid Rafts” (San Feliu de Guixols, Spain). |
| 2001 |
|
The Second ASO International Meeting on Thrombosis,
Hemostasis and Vascular Science, “Mapping vascular endothelia
and caveolae: From basic mechanisms of trafficking & signaling
to targeting organs & tumor angiogenesis in vivo” (Kumamoto,
Japan) |
| 2001 |
|
American Thoracic Society annual meeting, Scientific
Symposium on Targeting of pulmonary vasculature, "Lung-specific
targeting of caveolae in vivo to overcome key barriers to drug and
gene delivery" (San Fransisco, CA) |
| 2001 |
|
International Conference on Glycoconjugates and Contact
Structures of the Cell Surface, “Differential trafficking and
signaling via caveolae and glycolipid rafts” (Bonn, Germany) |
| 2001 |
|
APS Microcirculatory Society President’s Symposium
on Signaling Mechanisms of Endothelial Nitric Oxide, “Mechano-activation
of vascular endothelium via eNOS and Caveolae” (Orlando, FL) |
| 2001 |
|
Keith R. Porter Symposium on Cytoplasmic Organization
and Membrane Traffic, “Signal Integration & Trafficking
by Caveolae & Lipid Rafts” (Washington, DC) |
| 2001 |
|
American Association for Cancer Research on Oncogenomics, “Vascular
oncoproteomics for tissue-specific targeting & overcoming to
drug & gene delivery in vivo” (Tucson, AZ) |
| 2000 |
|
University of California Biomedical Sciences Conference, “Mapping
vascular endothelia and caveolae: From basic mechanisms of trafficking & signaling
to targeting organs & tumor angiogenesis in vivo” (Riverside,
CA) |
| 2000 |
|
ESF/EMBO: Frontiers of Cellular Microbiology and
Cell Biology, “Integration of Signaling and Trafficking
by Caveolae,” (Giens, France) |
| 2000 |
|
IBC Conference on Proteomics, “Accessible
Functional Proteomics: Valid Tissue and Tumor-Specific Vascular Targets
for Overcoming Barriers to Drug & Gene Delivery in Vivo” (Phoenix,
AZ) |
| 2000 |
|
American Society for Cancer Research on Angiogenesis
and Cancer: Basic Mechanisms to Therapeutic Applications, “Accessible
Functional Vascular Proteomics: Targeting Endothelium and Caveolae
for Tumor- and Tissue-Specific Pharmacodelivery Overcoming Key
Barriers in Vivo” (Traverse City, Michigan) |
| 2000 |
|
International Conference on Biochemistry of Lipids, "Formation
and function of caveolae" (Halle, Germany) |
| 2000 |
|
American Thoracic Society annual meeting, Scientific
Symposium on Targeting of drugs and genes to pulmonary vasculature, "Tissue-specific
vascular targeting of caveolae in vivo to overcome key barriers to
drug and gene delivery" (Toronto, Canada) |
| 2000 |
|
8th International Conference on Peace through Mind/Brain
Science: Photonics in imaging gene expression, "Tissue-specific
vascular targeting" ( Hamamatsu, Japan) |
| 1999 |
|
American Society of Cell Biology annual meeting, Scientific
symposia on Raftology: Lipid microdomains and membrane function, "Differential
cell surface dynamics of antibodies targeting caveolae vs. GPI-rich
rafts: Rapid vs. delayed endocytosis" (Washington D.C.) |
| 1999 |
|
International Conference on Functional Proteomics, "Accessible
target discovery through vascular proteomics” (San Diego, CA) |
| 1999 |
|
ASN Basic Science Conference on Horizons in vascular biology
and therapy, "Targeting vascular endothelium and its caveolae
for tissue-specific drug and gene delivery in vivo" ( Miami,
FL) |
| 1999 |
|
American Heart Association annual meeting, Scientific
Session on Caveolae in cardiovascular signal transduction, "Dynamic
regulation of endothelial caveolae in vivo" (Atlanta, GA) |
| 1999 |
|
International Conference on Monoclonal Antibodies
for Cancer, "Tissue- and tumor-specific Immunotargeting
of endothelial caveolae to overcome barriers to therapy in vivo" (San
Diego, CA) |
| 1999 |
|
European Science Foundation Research Conferences on Membrane-dynamics
in endocytosis: Structure-function relationship, "Caveolae-mediated
endocytosis and transcytosis: Molecular mechanisms and targeted
delivery in vivo" (Crete, Greece) |
| 1999 |
|
Department of Energy Workshop on Imaging gene expression
in vivo, "Tissue-specific vascular targeting of caveolae
to overcome cell barriers to drug and gene delivery in vivo" (La
Jolla, CA) |
| 1999 |
|
IBC International Conference on Functional Proteomics, "Accessible
functional proteomics for target discovery" (Boston, MA) |
| 1999 |
|
Pfizer Conference, “Targeting vascular endothelium and its
caveolae for drug and gene delivery” (Groton, CT) |
| 1998 |
|
10th Annual Growth Factor & Signal Transduction
Symposium: Endocytosis and Intracellular Trafficking; "Molecular
mechanisms mediating trafficking by caveolae" (Ames, IA) |
| 1998 |
|
IBC: Drug Discovery Technology, "Proteomic
mapping of endothelium and its caveolae for targeted therapy in vivo" (Boston,
MA) |
| 1998 |
|
NATO Advanced Study Institute: Vascular Endothelium:
Mechanisms of cell signaling, "Caveolae as endothelial
cell surface signal and mechano-transducers" (Crete, Greece) |
| 1998 |
|
Experimental Biology '98 Blood Vessel Symposium, "Role
of dynamin in caveolae fission & internalization" |
| 1998 |
|
Experimental Biology '98 President's Symposium on
Angiogenesis & Microcirculation, "Tissue-specific vascular
targeting, caveolae and tumor angiogenesis" (San Francisco,
CA) |
| 1998 |
|
Keystone Symposium on The Endothelium, "Going beyond
caveolae as integrative sensors and transporters in endothelium to
vascular targets for therapy" (Lake Tahoe, NV) |
| 1998 |
|
International Workshop on Domain Organization in
Membranes: Biological Implications, "Caveolae as cell
surface microdomains integrating vesicular transport with signal
transduction" (Jerusalem, Israel) |
| 1998 |
|
Gordon Conference on Drug Carriers in Medicine & Biology, "Tissue-specific
vascular targeting to overcome the endothelial cell barrier for drug & gene
delivery" (Ventura, CA) |
| 1998 |
|
USA/Japan NCI Conference on Tumor Angiogenesis, "Molecular
mapping and vascular targeting of the endothelial cell surface and
its caveolae for drug and gene therapy" (Maui, Hawaii) |
| 1998 |
|
Jennifer Jones Symposium on Innovations in Prostate & Epithelial
Cell Biology, "Targeting vascular endothelium and caveolae
for tumor ablation and tissue-specific gene and drug delivery" (Los
Angeles, CA) |
| 1997 |
|
Annual ASCB Meeting Symposium: Mechanism of vesicle
formation and budding, "Molecular Mechanisms for the Fission
and Internalization of Caveolae" (Washington D.C.) |
| 1997 |
|
International Symposia on GPI-anchored Proteins in Biological
Membranes, "Dynamics of GPI-anchored proteins and caveolae" (Splugen,
Switzerland) |
| 1997 |
|
CaP Cure Annual Symposia for the Cure of Prostate
Cancer, "Tissue-specific Vascular Targeting & Tumor
Therapy" (Lake Tahoe, NV) |
| 1997 |
|
Gordon Research Conference on Angiogenesis and
Microcirculation (Newport, RI) |
| 1997 |
|
Experimental Biology 97: Cellular & Molecular
Basis of Capillary Permeability - Chairman & speaker (New Orleans,
LA) |
| 1997 |
|
Vascular Biology '97 : Caveolae as cell surface mechanotransducers
sensitive to flow (New Orleans, LA) |
| 1997 |
|
Cold Spring Harbor Laboratory: Vector Targeting
Strategies for Therapeutic Gene Delivery |
| 1997 |
|
Keystone Symposium on Inflammation, Growth-Regulatory Molecules
and Atherosclerosis (Keystone, CO) |
| 1996 |
|
Sixth World Congress for Microcirculation, "Vascular
targets in endothelium induced by tumor angiogenesis in vivo" (Munich,
Germany) |
| 1996 |
|
Third Haverian-Texan Conference Sponsored by Bayer
AG - "Vascular Endothelium in Health and Disease" (Berlin,
Germany) |
| 1996 |
|
American Heart Association Conference on Pathogenesis
and Treatment of Pulmonary Edema (Sedalia, CO) |
| 1996 |
|
Sixth World Congress for Microcirculation on Cell
Biology of the Microvascular Barrier: Responses to injury (Munich,
Germany) |
| 1996 |
|
Sixth World Congress for Microcirculation on Mechanisms
of Regulation of Microvascular Permeability (Munich, Germany) |
| 1996 |
|
The Wellcome Trust Conference on New Perspectives in Microvascular
Fluid Exchange: A hundred years after Starling (London, UK) |
| 1996 |
|
ASCB Symposium on Structure & Function of Caveolae -
Chairman & speaker. |
| 1995 |
|
Biomedical Engineering Society Annual Meeting on New approaches
to mechanotransduction (Boston, MA) |
| 1995 |
|
Gordon Research Conference on Angiogenesis and Microcirculation,“Vascular
targets for anti-cancer therapy”(Newport, RI) |
| 1995 |
|
McGill Univ. Goresky Symposium on Cellular Metabolism: Capillary
permeation, cellular transport and reaction kinetics (Montreal,
Canada) |
| 1993 |
|
Gordon Research Conference on Physicochemical Aspects of Water,
Solute and Cell Exchange. |
| 1993 |
|
FASEB Symposium on Atherosclerosis. |
| 1991 |
|
FASEB Symposium on Endothelial Cell Biology. |
| 1989 |
|
FASEB Symposium on Recent Advances in the Physiology of Vascular
Endothelium. |
| 1988 |
|
International Congress of Cell Biology on Endothelial Cell
Biology. |
| 1988 |
|
Gordon Research Conference on Physicochemical Aspects of Water
and Solute Exchange. |
 |
|
|
